Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-21

Clinical Trial Update: Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: a Randomized Clinical Trial [Phase 2]

View source ↗

Summary

A completed Phase 2 randomized trial evaluating whether health beliefs and improved glycemic control can prevent cognitive decline in African Americans with dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Thomas Jefferson University | Conditions: Mild Cognitive Impairment, Diabetes | Phase 2 | Status: COMPLETED